The Future Of Mitochondria-Derived Peptides - Prof Pinchas Cohen Ep6

In this video Dr Cohen talks CohBar, a company that he co-founded with Professor Nir Barzilai and some of the work they are doing, as well as the latest developments in his lab. He also discusses the need for precision medicine in addressing diseases of aging.

Mitochondrial DNA variation in Alzheimer’s disease reveals a unique microprotein called SHMOOSE

https://www.nature.com/articles/s41380-022-01769-3

Professor Pinchas Cohen is the dean of the USC Leonard Davis School of Gerontology. He is a pioneer in the emerging science of mitochondria-derived peptides and their possible therapeutic benefits for diabetes, Alzheimer's and other diseases of aging, an area which remains the focus of his current research.

Mitochondria-derived peptides in aging and healthspan

https://pubmed.ncbi.nlm.nih.gov/35499074/

Dr Cohen's page at USC

https://gero.usc.edu/faculty/cohen/

The Cohen Lab

https://gero.usc.edu/labs/cohenlab/

CohBar Inc. Web site

https://www.cohbar.com/